Altium Capital Management LP Portfolio Holdings

Altium Capital Management LP

  • $177 Million
  • Q1 2024

Altium Capital Management LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $177 Million distributed in 72 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vera Therapeutics, Inc. with a value of $30.6M, Xenon Pharmaceuticals Inc. with a value of $15M, Axsome Therapeutics, Inc. with a value of $11M, Adma Biologics, Inc. with a value of $10.2M, and Avadel Pharmaceuticals PLC with a value of $9.34M.

Examining the 13F form we can see an increase of $66.3M in the current position value, from $111M to 177M.

Altium Capital Management LP is based out at New York, NY

Below you can find more details about Altium Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $177 Million
Healthcare: $174 Million
Consumer Cyclical: $3.13 Million
Technology: $160,000
Financial Services: $3,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.03B
$30.6 Million 17.25% of portfolio
710,000
Q1 2024 Added 15.45%
$2.37B
$15 Million 8.44% of portfolio
348,000
Q1 2024 Added 19.78%
$3.15B
$11 Million 6.2% of portfolio
138,000
Q4 2023 Added 50.0%
$1.88B
$10.2 Million 5.73% of portfolio
1,540,000
Q1 2024 Added 40.64%
$966M
$9.34 Million 5.26% of portfolio
553,057
Q1 2024 New
$77.9M
$8.95 Million 5.04% of portfolio
7,647,873
Q1 2024 Reduced 4.73%
$1.66B
$7.97 Million 4.49% of portfolio
500,000
Q1 2024 Added 29.87%
$6.35B
$7.82 Million 4.41% of portfolio
113,000
Q1 2024 Added 59.15%
$4.77B
$6.97 Million 3.93% of portfolio
85,000
Q1 2024 New
$391M
$6.85 Million 3.86% of portfolio
605,000
Q1 2024 Added 46.27%
$466M
$6.65 Million 3.75% of portfolio
1,335,000
Q1 2024 Added 0.15%
$58.1M
$5.72 Million 3.22% of portfolio
13,953,488
Q1 2024 New
$356M
$5.57 Million 3.14% of portfolio
405,000
Q1 2024 Reduced 40.09%
$346M
$5.28 Million 2.97% of portfolio
695,000
Q1 2024 New
$883M
$5.22 Million 2.94% of portfolio
208,000
Q1 2024 New
$7.54B
$3.78 Million 2.13% of portfolio
25,000
Q4 2023 New
$7.46B
$3.26 Million 1.83% of portfolio
120,000
Q4 2023 New
$412M
$3.13 Million 1.76% of portfolio
800,000
Q1 2024 New
$0
$3.09 Million 1.74% of portfolio
77,848
Q1 2024 Reduced 1.11%
$154M
$2.83 Million 1.6% of portfolio
665,000
Q1 2024 New
$1.99B
$2.48 Million 1.4% of portfolio
57,271
Q1 2024 Added 783.13%
$45M
$2.17 Million 1.22% of portfolio
1,212,882
Q1 2024 New
$144M
$2.01 Million 1.13% of portfolio
142,532
Q1 2024 Reduced 80.48%
$170M
$1.69 Million 0.95% of portfolio
341,461
Q1 2024 New
$13.9M
$1.6 Million 0.9% of portfolio
3,012,608
Q1 2024 New
$80.9M
$1.48 Million 0.83% of portfolio
2,111,731
Q1 2024 Added 5.59%
$77.4M
$1.12 Million 0.63% of portfolio
740,000
Q2 2023 Added 46.31%
$17.4M
$908,000 0.51% of portfolio
1,150,000
Q1 2024 New
$1.6M
$442,000 0.25% of portfolio
724,942
Q1 2024 New
$98.1M
$369,000 0.21% of portfolio
535,657
Q1 2024 New
$0
$162,000 0.09% of portfolio
225,000
Q4 2021 New
$937K
$160,000 0.09% of portfolio
135,292
Q1 2024 New
$0
$10,000 0.01% of portfolio
200,000
Q4 2021 New
$1.49M
$19,000 0.01% of portfolio
150,000
Q4 2022 New
Marinus Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 11.58%
-
$0 0.0% of portfolio
-
Q4 2022 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 45.75%
-
$0 0.0% of portfolio
-
Q3 2023 Reduced 96.0%
$0
$2,000 0.0% of portfolio
82,233
Q3 2021 New
$0
$0 0.0% of portfolio
18,823
Q4 2022 Reduced 98.0%
Boundless Bio Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Bitcoin Depot Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Biohaven LTD
-
$0 0.0% of portfolio
-
Q1 2024 New
Azitra Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
-
$0 0.0% of portfolio
-
Q3 2022 New
$0
$3,000 0.0% of portfolio
100,000
Q1 2023 New
Alimera Sciences Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 4.14%
Achieve Life Sciences Inc
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 72
  • Current Value $177 Million
  • Prior Value $111 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 25 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email